A Multifaceted Intervention to Improve Bleeding Management Among Patients Using Oral Anticoagulants (IMPACT-BLEEDING)

Platelet Antisedimentation Rate and Multiplate Exams in Patients on Antiplatelet Therapy and Controls

NCT03679858 ·Status: UNKNOWN

Efficacy and Safety of Prothromplex Total (Prothrombin Complex Concentrate) in Oral Anticoagulant Reversal

NCT01159210 ·Status: COMPLETED ·Phase: PHASE4

Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in Thrombosis

NCT00005684 ·Status: COMPLETED

Evaluation of the Impact of an Expert Opinion During the Management of Patients With Severe Bleeding on Oral Anticoagulants.

NCT05928091 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Bleeding Events After Triple Antithrombotic Therapy Initiation.

NCT03203980 ·Status: UNKNOWN

The Randomized OPTIMAL-ACT Trial

NCT03772613 ·Status: COMPLETED ·Phase: PHASE2

Oritavancin on the Results of Multiple Coagulation Tests in Healthy Volunteers

NCT02357524 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants

NCT06582563 ·Status: NOT_YET_RECRUITING

Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

NCT05641142 ·Status: RECRUITING ·Phase: NA

Administration of Fibrinogen Concentrate for Refractory Bleeding

NCT05091684 ·Status: TERMINATED ·Phase: PHASE2

Prospective Trial of a Validated Algorithm for Warfarin Dosing

NCT02705976 ·Status: COMPLETED ·Phase: NA

Dalteparin's Influence on Renally Compromised: Anti-Ten-A Study (DIRECT)

NCT00138099 ·Status: COMPLETED

Keeping Oral o Parental AnticoaguLation in the Acute Phase of Cardioembolic Ischemic Stroke

NCT05486351 ·Status: UNKNOWN

Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism

NCT00788736 ·Status: COMPLETED

Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.

NCT01727453 ·Status: COMPLETED ·Phase: PHASE4

Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse Events

NCT02103101 ·Status: COMPLETED ·Phase: NA

Efficacy of Direct Oral Anticoagulants as a Prophylactic Anticoagulation of Catheter Induced Thrombosis

NCT05705076 ·Status: UNKNOWN ·Phase: NA

Direct Oral Anticoagulants and Venous Thromboembolism

NCT02833987 ·Status: COMPLETED

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets

NCT05627375 ·Status: RECRUITING ·Phase: PHASE3

Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies

NCT03157154 ·Status: COMPLETED

Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients

NCT04412304 ·Status: COMPLETED

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

NCT00942968 ·Status: COMPLETED ·Phase: PHASE4

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study

NCT03292666 ·Status: COMPLETED

Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure

NCT06429787 ·Status: RECRUITING

A Study to Determine the Inter/Intra Observer and Intra-subject Variability of Whole Blood Clotting Time Measurements

NCT02205827 ·Status: COMPLETED ·Phase: NA